Susan Dexter is Chief Technical Officer of Sonnet BioTherapeutics Holdings Inc.
Person profile
Roles
Sonnet BioTherapeutics
Chief Technical Officer
Address
Princeton, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sonnet BioTherapeutics Holdings, Inc.
15 Jun 23
4
Sonnet BioTherapeutics Holdings, Inc.
17 Feb 23
4
Sonnet BioTherapeutics Holdings, Inc.
22 Dec 22
4
Sonnet BioTherapeutics Holdings, Inc.
8 Apr 22
4
Sonnet BioTherapeutics Holdings, Inc.
28 May 21
4
Sonnet BioTherapeutics Holdings, Inc.
2 Jul 20
3
Sonnet BioTherapeutics Holdings, Inc.
3 Apr 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | SONN Sonnet BioTherapeutics | Common Stock | Buy | Acquire P | No | No | 0.7 | 10,000 | 7.00 k | 33,667 |
7 Jan 23 | SONN Sonnet BioTherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 14,627 | 0.00 | 23,667 |
7 Jan 23 | SONN Sonnet BioTherapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 14,627 | 0.00 | 9,040 |
14 Dec 22 | SONN Sonnet BioTherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 14,627 | 0.00 | 141,199 |